01254 733163 pa@drbanypersad.co.uk

Publications

From abstracts and peer reviewed journal articles to writing a book

Publications

Books:

  1. Banypersad SM, Pearce K, “Successful Accreditation in Echocardiography” Wiley-Blackwell, ISBN 10 : 0470656921, Paperback. (Mar 2012)


Peer-Reviewed Journal Articles:

  1. Banypersad SM. The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis. Magn Reson Insights. 2019 May 1;12: 1-10.
  2. Maestrini V, Birtolo LI, Cimino S, Severino P, Mancone M, Francone M, Banypersad SM, Ventriglia F, Tritapepe L, Miraldi F, Fedele F. Giant right atrium and subvalvular pulmonary stenosis: A case report of an interesting combination. Echocardiography. 2019 May;36(5):992-995
  3. Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC. Response to Letters regarding “Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis”. Circulation. 2016 Mar 22;133(12):e450.
  4. Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2016 Mar 22;133(12):e450-1.
  5. Treibel TA, Zemrak F, Sado DM, Banypersad SM, White SK, Maestrini V, Barison A, Patel V, Herrey AS, Davies LC, Caulfield MJ, Petersen SE, Moon JC. Extracellular Volume Quantification in Isolated Hypertension – changes at the detectable limits? JCMR 2015, 17(1), 74.
  6. Fontana M, Banypersad SM, Treibel TA, Abdel-Gadir A, Maestrini V, Lane T, Gilbertson JA, Hutt DF, Lachmann HJ, Whelan CJ, Wechalekar AD, Herrey AS, Gillmore JD, Hawkins PN, Moon JC. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study. Radiology. 2015 May 21:141744.
  7. Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, Piechnik SK, Whelan CJ, Herrey A, Gillmore JD, Lachmann HJ, Wechalekar AD, Hawkins PN, Moon JC. T1 mapping and Survival in Systemic AL Amyloidosis. EHJ 2015. 23; 36(4): 244-51
  8. Sado DM, Maestrini V, Piechnik SK, Banypersad SM, White SK, Flett AS, Robson MD, Neubauer S, Ariti C, Arai A, Kellman P, Yamamura J, Schoennagel BP, Shah F, Davis B, Trompeter S, Walker M, Porter J, Moon JC. Non-contrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. J Magn Reson Imaging. 2015;41(6):1505-11.
  9. Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, Pica S, Castelletti S, Piechnik SK, Robson MD, Gilbertson JA, Rowczenio D, Hutt DF, Lachmann HJ, Wechalekar AD, Whelan CJ, Gillmore JD, Hawkins PN, Moon JC. “Native T1 mapping in transthyretin amyloidosis” JACC Cardiovasc Imaging. 2014 Feb;7(2):157-65.
  10. Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD, Dungu J, Banypersad SM, Wechalekar AD, Whelan CJ, Hawkins PN, Gillmore JD. “Systemic amyloidosis in England: An Epidemiological study.” Br J Haem 2013 May;161(4):525-32. doi: 10.1111/bjh.12286.
  11. Bandula S, Banypersad SM, Sado D, Flett AS, Punwani S, Taylor SA, Hawkins PN, Moon JC. Measurement of Tissue Interstitial Volume in Healthy Patients and Those with Amyloidosis with Equilibrium Contrast-enhanced MR Imaging. Radiology. 2013 May 14
  12. Pinney JH, Whelan CJ, Petrie A, Dungu J, Banypersad SM, Sattianayagam P, Wechalekar A, Gibbs SD, Venner CP, Wassef N, McCarthy CA, Gilbertson JA, Rowczenio D, Hawkins PN, Gillmore JD, Lachmann HJ. “Senile systemic amyloidosis: clinical features at presentation and outcome.” J Am Heart Assoc. 2013 Apr 22;2(2):e000098
  13. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC. “T1 Mapping for Myocardial Extracellular Volume Measurement by CMR: Bolus Only Versus Primed Infusion Technique.” JACC Cardiovasc Imaging. 2013 Apr 5
  14. Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC. “The Identification and Assessment of Anderson Fabry Disease by Cardiovascular Magnetic Resonance Non-Contrast Myocardial T1 Mapping.” Circ Cardiovasc Imaging. 2013 1;6(3), 392-8.
  15. Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC. “Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.” JACC Cardiovasc Imaging. 2013 Apr;6(4):488-97
  16. Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N, Moon JC. “Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.” J Cardiovasc Magn Reson. 2012 Dec 28; 14: 88-96
  17. Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, Cox AT, Fontana M, Whelan CJ, Wechalekar AD, Hawkins PN, Moon JC. “Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.” Circ Cardiovasc Imaging. 2013 Jan 1;6(1):34-9
  18. Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc. 2012 Apr;1(2):e000364
  19. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012 Oct;98(19):1436-41
  20. Dungu J, Sattianayagam PT, Whelan CJ, Gibbs SD, Pinney JH, Banypersad SM, Rowczenio D, Gilbertson JA, Lachmann HJ, Wechalekar A, Gillmore JD, Hawkins PN, Anderson LJ. The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients. Am Heart J. 2012 Jul;164(1):72-9
  21. Motwani M, Banypersad SM, Woolfson P, Waldek S. Enzyme replacement therapy improves cardiac features and severity of Fabry disease. Mol Genet Metab. 2012 Sep;107(1-2):197-202
  22. Banypersad SM, Schmitt M. Atrial SOL – a multimodality imaging approach. British Journal of Cardiology 2010, 17(3), 148-50
  23. Banypersad SM, Daly ME, Makris M. The Common Haemochromatosis Mutation Does Not Increase the Risk of Thrombosis in Patients with Factor V Leiden. British Journal of Haematology 1999 Jun, 105(3), 842-44 [letter]


Abstracts:

  1. Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Sado DM, Bulluck H, Lane TL, Lachmann H, Whelan C, Wechalekar AD, Manisty C, Herrey AS, Kellman P, Hawkins PN, Moon JC. LGE-PSIR is an Independent Predictor of Mortality in Cardiac Amyloidosis: a 250 patient prospective study. JCMR 2015, Volume 17 Suppl 1.
  2. Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, Castaletti S, Herrey AS, Hawkins PN, Moon JC. Native T1 mapping in ATTR cardiac amyloidosis – comparison with AL Amyloidosis – a 200 patient study. JCMR 2014, Volume 16 Suppl 1.
  3. Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, Bulluck H, Herrey AS, Hawkins PN, Moon JC. AL and ATTR Cardiac Amyloid are different: native T1 mapping and ECV detect different pathologies. JCMR (2014), Volume 16 Suppl 1.
  4. Treibel T, White SK, Sado DM, Zemrak F, Banypersad SM, Flett AS, caulfield M, Herrey AS, Petersen SE, Moon JC. “Interstitial Expansion in pressure overload left ventricular hypertrophy.” JCMR (2013), 15 (suppl. 1) doi:10.1186/1532-429X-15-S1-O92
  5. Mahmood S, Venner CP, Lane T, Rannigan L, Foard D, Pinney J, Banypersad SM, Dungu J, Whelan C, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar A, “Continuous Therapy with Lenalidomide Correlates with Improved Progression Free Survival in Heavily Pre-Treated Patients with AL Amyloidosis.” Blood (2012); 120(21), 2978
  6. Venner CP, Lane T, Foard D, Rannigan L, Mahmood S, Gibbs SDJ, Pinney J, Banypersad SM, Dungu J, Whelan C, Lachmann H, Gillmore JD, Hawkins PN, Wechalekar A, “A Matched Comparison of Cyclophosphamide, Bortezomib and Dexamethasone (CVD) Versus Cyclophosphamide, Thalidomide and Dexamethasone (CTD) in the Treatment of Mayo Cardiac Stage III Patients with AL Amyloidosis.” Blood (2012); 120(21), 2966
  7. Lane T, Rannigan L, Foard D, Wechalekar A, Gibbs S, Pinney J, Venner CP, Banypersad SM, Lachmann H, Hawkins PN, Gillmore JD, “ALchemy – A Large Prospective ‘Real World’ Study of Chemotherapy in AL Amyloidosis” Blood (2011); 118(21), 453
  8. Pinney JH, Lachmann HJ, Gillmore JG, Wechalekar A, Gibbs SD, Sattianayagam P, Banypersad SM, Dungu J, Wassef N, McCarthy CA, Hawkins PN, Whelan CJ. Senile Systemic Amyloidosis: A common cause of heart failure in the elderly? Heart (2011); 97(Suppl 1), 59-60
  9. Banypersad SM, Makris M, Daly ME, Peake IR, Preston FE, “Increased Prevalence of Compound Heterozygosity for C677T and A1289C in Patients with Factor V Leiden and Venous Thromboembolism.” 17th Congress of International Society of Thrombosis and Haemostasis (1999), 212
  10. Banypersad SM, Makris M, Jarvis L, Underwood JCE, Preston FE, “Infection with Transfusion-Transmitted Virus and Heterozygosity for C282Y Mutation in Chronic Hepatitis-C infected Haemophiliacs.” 17th Congress of International Society of Thrombosis and Haemostasis (1999), 1501
  11. Carter MJ, Sanders DS, Banypersad SM, Sorrell J, Makris M, Lobo AJ, “Increased Frequency of Methylene Tetrahydrofolate Reductase C677T Variant in Patients with Inflammatory Bowel Disease and Thrombosis.” 18th Congress of International Society of Thrombosis and Haemostasis (2001), 3574

Tests with Dr Banypersad

Cardiac MRI

A non-invasive test that uses an MRI machine to create magnetic and radio waves to show detailed pictures of the inside of your heart.

Read more

Cardiac CT

A heart-imaging test that uses CT technology with intravenous (IV) contrast (dye) to visualize the heart anatomy, and coronary circulation.

Read more

Echocardiography

A test that uses ultrasound waves to produce live images of your heart which show how your heart and its valves are functioning.

Read more

Appointment

Dr Banypersad can help you with these tests. Through an appointment he will be able to advise you on the best course of action.

Read more